VC firm
TVM Capital
- Investor type
- VC
- Investing status
- Activeas of 2026-09-20Source (opens in a new tab)
- Founded
- 1983
- tvm-capital.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Team page (opens in a new tab)
Claim, correct or request removal
Record updated 20 September 2026
About
We provide capital and expertise to develop and market products with the potential to transform medical practice while building value for our investors.
Investment approach
- Thesis
- This involves creating single-asset companies to bring early-stage therapeutics to clinical proof of concept, aided by a strategic partnership with global pharmaceutical company Eli Lilly and Company (Lilly). In addition, we invest in companies with commercial-stage medtech, diagnostics, and digital health and late-stage therapeutics with the potential to change standard of care.Source (opens in a new tab)
- Takes board seats
- Yes
- Board policy
- He currently serves as Chairman of the board of directors for leon nanodrugs GmbH and AL-S Pharma AG.
- Investing status notes
- We invest in the development of exciting life science programs and the growth of current or future innovative market segment leaders.
Locations
- Office
- Montreal
- Office
- Munich
Loading relationship preview